SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0000950170-24-003362
Filing Date
2024-01-09
Accepted
2024-01-09 16:24:53
Documents
5
Effectiveness Date
2024-01-09

Document Format Files

Seq Description Document Type Size
1 S-8 2024_s-8.htm S-8 110634
2 EX-5.1 kalv-ex5_1.htm EX-5.1 16465
3 EX-23.1 kalv-ex23_1.htm EX-23.1 2399
4 EX-FILING FEES kalv-exfiling_fees.htm EX-FILING FEES 24456
5 GRAPHIC img28983514_0.jpg GRAPHIC 32230
  Complete submission text file 0000950170-24-003362.txt   199863
Mailing Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142
Business Address 55 CAMBRIDGE PARKWAY SUITE 901E CAMBRIDGE MA 02142 (857) 999-0075
KalVista Pharmaceuticals, Inc. (Filer) CIK: 0001348911 (see all company filings)

IRS No.: 200915291 | State of Incorp.: DE | Fiscal Year End: 0430
Type: S-8 | Act: 33 | File No.: 333-276444 | Film No.: 24523549
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)